SENS compared with ALGS: revenue, margins and what each company keeps, and the suppliers and customers both name

SENSSenseonics Holdings, Inc.

Mkt capRevenueRevenue

ALGSAligos Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SENSSenseonics Holdings, Inc.

ALGSAligos Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SENS 3

—BSIunlistedsupplier

—NPGunlistedsupplier

—Ascensia Diabetes Care Holdings AG ("Ascensia")unlistedcustomer

Shared 0

No shared counterparties.

Only ALGS 15

MRKMerck Sharp & Dohmecustomer

ADCTADC Therapeutics (ADCT)customer

—Emory Universityunlistedsupplier

—Rega Institute at Katholieke Universiteit Leuven (KU Leuven)

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

11 more · ALGS chain ›

SENSSenseonics Holdings, Inc.

8.57▲+7.25%· post 8.57

Mkt cap$422.5MRevenue$14MQ2 FY26Revenue$35MFY25

ALGSAligos Therapeutics, Inc.

4.15▼−7.98%· post 4.15

ClosedNov 6 '26

Mkt cap$50.9MRevenue$3MQ3 FY26Revenue$2MFY25

Compare

ClosedNov 6 '26

SENSSenseonics Holdings, Inc.

ALGSAligos Therapeutics, Inc.

8.57▲+7.25%post 8.57

Price

4.15▼−7.98%post 4.15

$422.5M

Mkt cap

$50.9M

Q2 FY26$14M

Revenue

$3MQ3 FY26

FY25$35M

Revenue

$2MFY25

SENS8.57▲+7.25%vsALGS4.15▼−7.98%ClosedNov 6 '26